Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 12 Nov 2026

AUROPHARMA, full dossier

Eugia US LLC, a subsidiary of Aurobindo Pharma, has initiated a voluntary recall of vancomycin hydrochloride due to the presence of glass particles in the drug vials.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Eugia US LLC, a subsidiary of Aurobindo Pharma, has initiated a voluntary recall of vancomycin hydrochloride due to the presence of glass particles in the drug vials.

indiatimes.com12 Nov 2026

A single act of reporting so far, corroborating sources join this record as they publish.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.